Outcomes of PD for AKI treatment during COVID-19 in New York City: A multicenter study.

Maryanne Y SourialAnirudh GoneJaime UribarriVesh SrivatanaShuchita SharmaDaniil ShimonovMichael ChangWenzhu MowreyRochelle DalsanKaltrina SedaliuSwati JainMichael J RossNina CaplinWei Chennull null

Published in: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2022)

The use of PD for the treatment of AKI was not associated with worse clinical outcomes when compared to extracorporeal dialysis during the height of the COVID-19 pandemic in New York City. Given the inherent selection biases and residual confounding in our observational study, research with a larger cohort of patients in a more controlled setting is needed to confirm our findings.

Keyphrases

end stage renal disease
chronic kidney disease
acute kidney injury
peritoneal dialysis
newly diagnosed
prognostic factors
skeletal muscle
adipose tissue
replacement therapy
patient reported